ReviewCurrent pharmaceutical biotechnology2025
Trojan Horses: A Secret Route for Nanomedicines.
Review in Current pharmaceutical biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The nanoparticles are widely used in various drug delivery applications due to their versatility to encapsulate, cargo loading, and transport of therapeutic agents. Numerous studies have explored the use of nanomedicine-based drug delivery systems for treating various diseases. This research provides a smart and precise review of one of the nanoparticles-based drug delivery approaches, i.e., the Trojan horse strategy which is employed for delivering the drug to the target efficiently and reliably. Furthermore, the applicability of nanomedicines to cancer treatment is discussed, with examples drawn from various systematic studies. The use of different nanomedicine platforms such as liposomes, nanoparticles, spherical nucleic acids, extracellular vesicles, and immune cells acting as Trojan horses is also explored in the context of cancer therapy. Finally, a precise conclusion and future recommendations are provided for future researchers in the field of applied nanotechnology for the pharmaceutical domain.
Indexed as
Identifiers
40390216What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.